Immune protection against virus challenge in aging mice is not affected by latent herpesviral infections

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11715-11717

  Marandu, Thomas F ^a,c   Oduro, Jennifer D ^a   Borkner, Lisa ^a   Dekhtiarenko, Iryna ^a   Uhrlaub, Jennifer L ^e   Drabig, Anja ^a   Kröger, Andrea ^a   Nikolich Zugich, Janko ^d,e   Cicin Sain, Luka ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF DAR ES SALAAM   (Tanzania)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; GAMMAHERPESVIRINAE; HERPES SIMPLEX; HERPES VIRUS INFECTION; HOMEOSTASIS; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VESICULAR STOMATITIS; VIRUS STRAIN; WEST NILE VIRUS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MOUSE; MUROMEGALOVIRUS; ORTHOMYXOVIRIDAE; RHADINOVIRUS; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS LATENCY;

AGING; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; ORTHOMYXOVIRIDAE; RHADINOVIRUS; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS LATENCY; WEST NILE VIRUS;

EID: 84945957906     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01989-15     Document Type: Article

References (23)

1. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. 1998. Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839. http://dx.doi.org/10.1016/S0140-6736(97)09028-4.
2. Ocheni S, Kroeger N, Zabelina T, Sobottka I, Ayuk F, Wolschke C, Muth A, Lellek H, Petersen L, Erttmann R, Kabisch H, Zander AR, Bacher U. 2008. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplant 42:181-186. http://dx.doi.org/10.1038/bmt.2008.150.
3. Kameyama T, Sujaku C, Yamamoto S, Hwang CB, Shillitoe EJ. 1988. Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol 17:478-481. http://dx.doi.org/10.1111/j.1600-0714.1988.tb01320.x.
4. Russell MY, Palmer A, Michaels MG. 2011. Cytomegalovirus infection in pediatric immunocompromised hosts. Infect Disord Drug Targets 11: 437-448. http://dx.doi.org/10.2174/187152611797636686.
5. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. 2000. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121:187-201.
6. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. 2005. Human immunosenescence: is it infectious? Immunol Rev 205:257-268. http://dx.doi.org/10.1111/j.0105-2896.2005.00271.x.
7. Akbar AN, Fletcher JM. 2005. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 17:480-485. http://dx.doi.org/10.1016/j.coi.2005.07.019.
8. Le Saux S, Weyand CM, Goronzy JJ. 2012. Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci 1247:69-82. http://dx.doi.org/10.1111/j.1749-6632.2011.06297.x.
9. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C, Pawelec G. 2007. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 1114:23-35. http://dx.doi.org/10.1196/annals.1396.043.
10. Pawelec G, Ouyang Q, Colonna-Romano G, Candore G, Lio D, Caruso C. 2002. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol 23:330-332. http://dx.doi.org/10.1016/S1471-4906(02)02255-X.
11. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB. 2006. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450-458. http://dx.doi.org/10.4049/jimmunol.177.1.450.
12. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P. 2003. Memory inflation: continuous accumulation of antiviral CD8+T cells over time. J Immunol 170:2022-2029. http://dx.doi.org/10.4049/jimmunol.170.4.2022.
13. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ. 2000. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495-11503. http://dx.doi.org/10.1128/JVI.74.24.11495-11503.2000.
14. Komatsu H, Sierro S, Cuero AV, Klenerman P. 2003. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol 134:9-12. http://dx.doi.org/10.1046/j.1365-2249.2003.02266.x.
15. Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J. 2012. Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog 8:e1002849. http://dx.doi.org/10.1371/journal.ppat.1002849.
16. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F. 2002. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445-453. http://dx.doi.org/10.1016/S0531-5565(01)00212-1.
17. Smithey MJ, Li G, Venturi V, Davenport MP, Nikolich-Zugich J. 2012. Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life. J Immunol http://dx.doi.org/10.4049/jimmunol.1201867.
18. Beswick M, Pachnio A, Lauder SN, Sweet C, Moss PA. 2013. Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection. J Virol 87:779-789. http://dx.doi.org/10.1128/JVI.02427-12.
19. Furman D, Jojic V, Sharma S, Shen-Orr SS, Cesar J. L. Angel, Onengut-Gumuscu S, Kidd BA, Maecker HT, Concannon P, Dekker CL, Thomas PG, Davis MM. 2015. Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 7:281ra43. http://dx.doi.org/10.1126/scitranslmed.aaa2293.
20. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW, IV. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326-329. http://dx.doi.org/10.1038/nature05762.
21. Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski UH, Adler B. 2011. Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary glands due to a fixed mutation of MCK-2. J Virol 85:10346-10353. http://dx.doi.org/10.1128/JVI.00545-11.
22. Adler H, Messerle M, Koszinowski UH. 2001. Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J Virol 75:5692-5696. http://dx.doi.org/10.1128/JVI.75.12.5692-5696.2001.
23. Marandu TF, Finsterbusch K, Kroger A, Cicin-Sain L. 2014. Mouse CMV infection delays antibody class switch upon an unrelated virus challenge. Exp Gerontol 54:101-108. http://dx.doi.org/10.1016/j.exger.2014.01.017.